QS Investors’s Medicines Co MDCO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-1,900
| Closed | -$162K | – | 1737 |
|
|
2019
Q4 | $162K | Sell |
1,900
-1,200
| -39% | -$80K | ﹤0.01% | 1236 |
|
|
2019
Q3 | $155K | Sell |
3,100
-2,900
| -48% | -$116K | ﹤0.01% | 1269 |
|
|
2019
Q2 | $219K | Buy |
+6,000
| New | +$196K | ﹤0.01% | 1196 |
|
|
2018
Q4 | – | Sell |
-1,500
| Closed | -$45K | – | 1955 |
|
|
2018
Q3 | $45K | Hold |
1,500
| – | – | ﹤0.01% | 1497 |
|
|
2018
Q2 | $55K | Hold |
1,500
| – | – | ﹤0.01% | 1503 |
|
|
2018
Q1 | $49K | Hold |
1,500
| – | – | ﹤0.01% | 1478 |
|
|
2017
Q4 | $41K | Sell |
1,500
-11
| -0.7% | -$339 | ﹤0.01% | 1509 |
|
|
2017
Q3 | $56K | Hold |
1,511
| – | – | ﹤0.01% | 1499 |
|
|
2017
Q2 | $57K | Hold |
1,511
| – | – | ﹤0.01% | 1482 |
|
|
2017
Q1 | $74K | Buy |
1,511
+1,500
| +13,636% | +$68.4K | ﹤0.01% | 1439 |
|
|
2016
Q4 | $1K | Hold |
11
| – | – | ﹤0.01% | 1854 |
|
|
2016
Q3 | $1K | Sell |
11
-48,780
| -100% | -$1.84M | ﹤0.01% | 1853 |
|
|
2016
Q2 | $1.64M | Sell |
48,791
-845
| -2% | -$29.8K | 0.01% | 676 |
|
|
2016
Q1 | $1.58M | Sell |
49,636
-8
| -0% | -$261 | 0.02% | 684 |
|
|
2015
Q4 | $1.85M | Sell |
49,644
-3,558
| -7% | -$134K | 0.02% | 676 |
|
|
2015
Q3 | $2.02M | Sell |
53,202
-102,201
| -66% | -$3.59M | 0.02% | 618 |
|
|
2015
Q2 | $4.45M | Hold |
155,403
| – | – | 0.05% | 422 |
|
|
2015
Q1 | $4.36M | Hold |
155,403
| – | – | 0.05% | 418 |
|
|
2014
Q4 | $4.3M | Buy |
+155,403
| New | +$3.85M | 0.05% | 404 |
|
Other funds holding MDCO
QS Investors's MDCO Position: Q1 2020 in Review
QS Investors sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 1,900 shares — an estimated $162K sold.
QS Investors first reported a position in MDCO in Q4 2014 and held it in 19 quarters. The position peaked at $4.45M in Q2 2015. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.
- QS Investors reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
- QS Investors sold 1,900 Medicines Co shares in Q1 2020, an estimated $162K.
- QS Investors first reported a position in Medicines Co in Q4 2014 and held it in 19 quarters.
- QS Investors's Medicines Co position peaked at $4.45M in Q2 2015.
- 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.
Based on QS Investors's 13F filing for Q1 2020, filed 15 May 2020.